摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

succinic semialdehyde 2,4-dinitrophenylhydrazone | 4093-65-6

中文名称
——
中文别名
——
英文名称
succinic semialdehyde 2,4-dinitrophenylhydrazone
英文别名
β-Formyl-propionsaeure-(2,4-dinitro-phenylhydrazon);4-[(2,4-Dinitrophenyl)hydrazinylidene]butanoic acid
succinic semialdehyde 2,4-dinitrophenylhydrazone化学式
CAS
4093-65-6
化学式
C10H10N4O6
mdl
——
分子量
282.213
InChiKey
XIQVJSLOJWLIKA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    ≥200 °C

计算性质

  • 辛醇/水分配系数(LogP):
    0.2
  • 重原子数:
    20
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    153
  • 氢给体数:
    2
  • 氢受体数:
    8

安全信息

  • 海关编码:
    2928000090

SDS

SDS:cc59ab517a7f592ec0db3b9508b589db
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    参考文献:
    名称:
    Rate Enhancement by Micelle Encapsulation for Oxidation of L-Glutamic Acid in Aqueous Media at Room Temperature
    摘要:
    谷氨酸的氧化反应在酸性水介质中于$30^{\circ}C$下进行,动力学条件为[谷氨酸]$_T{\gg}[Cr(VI)]_T$。研究了表面活性剂催化剂(SDS、TX-100)与促进剂(PA、bpy、phen)组合的影响。在促进剂中,phen在水介质中最能加速反应,但加速效果较小。促进剂与催化剂的组合产生了更好的结果。当bpy与SDS组合存在时,反应速率增强达到最大。
    DOI:
    10.5012/jkcs.2013.57.4.425
点击查看最新优质反应信息

文献信息

  • Kinetics of oxidation of acidic amino acids and their monoamides byN-chloroarylsulphonamides in aqueous acidic medium
    作者:B. Thimme Gowda、Mahesha Shetty
    DOI:10.1002/poc.758
    日期:2004.10
    Twelve sodium salts of N-chloroarylsulphonamides were employed as oxidants for studying the kinetics of oxidation of two acidic amino acids (aspartic and glutamic acid) and their monoamides (aspargine and glutamine) in aqueous acidic medium under various conditions, to see how the oxidative strength of these reagents vary with substitution. The sodium salts of N-chloroarylsulphonamides employed are
    使用N-芳基磺酰胺的十二种钠盐作为氧化剂,研究了两种酸性氨基酸天冬氨酸和谷酸)及其单酰胺(天冬氨酸和谷酰胺)在性酸性介质中在各种条件下的氧化动力学,以了解其氧化强度这些试剂的种类随取代而变化。的钠盐Ñ -chloroarylsulphonamides采用是通式我-XC 6 ħ 4 SO 2 NaNCl· X ^ h 2 O(其中,我-X = 4-C 2 H ^ 5,4-F,4-Cl或4- Br)和i -X- j -YC6 ħ 3 SO 2 NaNCl· X ^ h 2 -O [其中我-X- Ĵ -Y = 2,3-(CH 3)2,2,4-(CH 3)2,2,5-(CH 3)2,2-CH 3 -4-Cl,2,4-Cl 2和3,4-Cl 2 ]。反应在[氧化剂]中显示出二级动力学,在[氨基酸]中显示出分数级,并且对[H +]。添加氧化剂的还原产物或介质的离子强度的变化对氧化速率没有显着
  • Julia,M.; Le Thuillier,G., Bulletin de la Societe Chimique de France, 1966, p. 717 - 728
    作者:Julia,M.、Le Thuillier,G.
    DOI:——
    日期:——
  • A Convenient Synthesis of 4-Oxobutanoic Acid (Succinic Semialdehyde) from 1,5-Cyclooctadiene
    作者:Ada Manzocchi、Franca Astori、Enzo Santaniello
    DOI:10.1055/s-1983-30326
    日期:——
  • Mechanism of inactivation of .gamma.-aminobutyric acid aminotransferase by 4-amino-5-hexynoic acid (.gamma.-ethynyl GABA)
    作者:James R. Burke、Richard B. Silverman
    DOI:10.1021/ja00024a042
    日期:1991.11
    Gamma-Aminobutyric acid (GABA) aminotransferase is a pyridoxal phosphate (PLP) dependent enzyme that catalyzes the degradation of gamma-aminobutyric acid. The inactivation of GABA aminotransferase has been shown to be an important treatment for epilepsy. The mechanism of inactivation of GABA aminotransferase by gamma-ethynyl GABA, a mechanism-based inactivator of GABA aminotransferase that shows anticonvulsant activity in animal models, is investigated in this paper. Although it appears that azaallylic isomerization (the normal catalytic pathway for substrates) of the PLP-bound inactivator occurs (pathway a, Scheme VII), little or no inactivation of the enzyme results from that isomerization. Essentially all of the inactivation is derived from a propargylic isomerization (pathway b) to the allenamine bound PLP adduct 10, which undergoes nucleophilic attack at two different sites. It appears that an active site lysine residue reacts at the Schiff base to give the free enamine 18 (pathway c) or reacts at the allene to give the enzyme and cofactor bound enamine 12 (pathway d); possible attack by water (pathway e) would lead to metabolite 26. The enamine 18 does not become attached to the PLP (Scheme III, pathway a), but a small amount (5-10%) may become attached to the enzyme at a site other than at lysine (9, Scheme III, pathway b). Adduct 9 also could be derived from azaallylic isomerization of the inactivator-PLP Schiff base followed by conjugate addition to the acetylene by an active site nucleophile other than a lysine residue (Scheme I). Mostly 18 is released into solution to give 27 (Scheme VII). Adduct 12 is believed to be a transient intermediate that partitions between conversion to metabolite 26 (Scheme VII, pathway f) and conversion to a more stable isomer (13, pathway g). Upon denaturation, adduct 13 partitions equally (Scheme VIII) between release of metabolite 26 and the formation of another covalent adduct (17). Isolation and identification of the amine and nonamine metabolites produced during processing of gamma-ethynyl GABA showed that, on average, for every 13 molecules of gamma-ethynyl GABA that are turned over, 1.2 undergoes transamination (pathway a, Scheme VII), 2.6 are metabolized to 27 (pathways b and c), 8.2 are converted to 26 (pathways b, d, and f and/or pathways b and e), and 1.0 becomes attached to the enzyme, almost all, as 13 (pathways b, d, and g), but possibly 5-10% as 9 (X not-equal Lys) as discussed above.
  • Abderhalden, Hoppe-Seyler's Zeitschrift fur Physiologische Chemie, 1938, vol. 252, p. 87
    作者:Abderhalden
    DOI:——
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫